Actuate Therapeutics ACTU
NASDAQ ACTU
$0.72 +0.04 (+5.38%)
As of: Sep 30, 2026 · 11:38 AM EDT

Actuate Therapeutics (ACTU) Enterprise Value (2024 - 2026)

Updated

Actuate Therapeutics (ACTU) posted Enterprise Value of $32.31 million for Q2 2026, down 72.7% from $118.58 million a year earlier.

Analysis

Actuate Therapeutics (ACTU) Enterprise Value (2024 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Enterprise Value at Actuate Therapeutics was -$4.26 million; for FY2025, it came in at $129.1 million, up 122.6% from FY2024.

  • In prior years, Actuate Therapeutics' Enterprise Value was $58.01 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Actuate Therapeutics 17.77 Mn 17.77 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 32.31 Mn
Dec 31, 2025 129.10 Mn
Sep 30, 2025 138.57 Mn
Jun 30, 2025 118.58 Mn
Mar 31, 2025 128.34 Mn
Dec 31, 2024 58.01 Mn
Sep 30, 2024 66.73 Mn
API Access

Actuate Therapeutics Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=ACTU&period=max&api_key=YOUR_API_KEY